Quantbot Technologies LP Verona Pharma PLC Transaction History

Quantbot Technologies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$15.3 - $20.24 $150,720 - $199,384	-9,851 Reduced 80.03%	2,458 $39,000
Q4 2023 Feb 14, 2024	BUY	$11.94 - $20.47 $137,477 - $235,691	11,514 Added 1448.3%	12,309 $244,000
Q3 2023 Nov 07, 2023	BUY	$16.3 - $22.09 $12,958 - $17,561	795 New	795 $12,000
Q4 2022 Feb 13, 2023	BUY	$9.84 - $26.13 $8,462 - $22,471	860 New	860 $22,000

167

68.7M

704K

685K

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $2.75B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.